» Articles » PMID: 37814898

Environmental and Microbial Factors in Inflammatory Bowel Disease Model Establishment: A Review Partly Through Mendelian Randomization

Overview
Journal Gut Liver
Specialty Gastroenterology
Date 2023 Oct 10
PMID 37814898
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammatory bowel disease (IBD) is a complex condition resulting from environmental, microbial, immunologic, and genetic factors. With the advancement of Mendelian randomization research in IBD, we have gained new insights into the relationship between these factors and IBD. Many animal models of IBD have been developed using different methods, but few studies have attempted to model IBD by combining environmental factors and microbial factors. In this review, we examine how environmental factors and microbial factors affect the development and progression of IBD, and how they interact with each other and with the intestinal microbiota. We also summarize the current methods for creating animal models of IBD and compare their advantages and disadvantages. Based on the latest findings from Mendelian randomization studies on the role of environmental factors in IBD, we discuss which environmental and microbial factors could be used to construct a more realistic and reliable IBD experimental model. We propose that animal models of IBD should consider both environmental and microbial factors to better mimic human IBD pathogenesis and to reveal the underlying mechanisms of IBD at the immune and genetic levels. We highlight the importance of environmental and microbial factors in IBD pathogenesis and offer new perspectives and suggestions for improving experimental animal modeling. Our goal is to create a model that closely resembles the clinical picture of IBD.

Citing Articles

Editorial: Interaction between the gut flora and immunity in intestinal diseases.

Li Y, Turroni S, Gong L, Shi D Front Immunol. 2024; 15:1458526.

PMID: 39188725 PMC: 11345215. DOI: 10.3389/fimmu.2024.1458526.


Gut microbiota and common gastrointestinal diseases: a bidirectional two-sample Mendelian randomized study.

Qiu B, Shen Z, Yang D, Qin X, Ren W, Wang Q Front Microbiol. 2023; 14:1273269.

PMID: 38045030 PMC: 10691374. DOI: 10.3389/fmicb.2023.1273269.

References
1.
Mahalhal A, Burkitt M, Duckworth C, Hold G, Campbell B, Pritchard D . Long-Term Iron Deficiency and Dietary Iron Excess Exacerbate Acute Dextran Sodium Sulphate-Induced Colitis and Are Associated with Significant Dysbiosis. Int J Mol Sci. 2021; 22(7). PMC: 8037348. DOI: 10.3390/ijms22073646. View

2.
Nystrom N, Prast-Nielsen S, Correia M, Globisch D, Engstrand L, Schuppe-Koistinen I . Mucosal and Plasma Metabolomes in New-onset Paediatric Inflammatory Bowel Disease: Correlations with Disease Characteristics and Plasma Inflammation Protein Markers. J Crohns Colitis. 2022; 17(3):418-432. PMC: 10069620. DOI: 10.1093/ecco-jcc/jjac149. View

3.
Ng S, Benjamin J, McCarthy N, Hedin C, Koutsoumpas A, Plamondon S . Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn's disease. Inflamm Bowel Dis. 2011; 17(10):2027-37. DOI: 10.1002/ibd.21590. View

4.
Jantchou P, Morois S, Clavel-Chapelon F, Boutron-Ruault M, Carbonnel F . Animal protein intake and risk of inflammatory bowel disease: The E3N prospective study. Am J Gastroenterol. 2010; 105(10):2195-201. DOI: 10.1038/ajg.2010.192. View

5.
Cheluvappa R, Luo A, Grimm M . Autophagy suppression by appendicitis and appendectomy protects against colitis. Inflamm Bowel Dis. 2014; 20(5):847-55. DOI: 10.1097/MIB.0000000000000034. View